Valorant has some striking designs for its custom knife, axes, daggers, and claw skins. Here are the best ones, ranked.

In Valorant, knowing how the economy system works is just as important as knowing how to shoot. Here’s all you need to know regarding Valorant’s economy — from the basics to general economic tips and ...

Whether you want to compete against the best of the best or you simply want to throw snowballs while skating, Valorant has a plethora of game modes for you to choose from. Here is a rundown of all the ...

Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Katana has completed the acquisition of IDEX, a veteran on-chain trading infrastructure team, and launched Katana Perps, its native perpetual futures ...

April 12, 2026: Viper and Chamber will see you now, as you redeem your For Retribution playercard, which we checked still works. We also hunted around to see if we could find any other codes, but ...

What are Valorant ranks? We've taken a deep dive into the Valorant ranking system to show you how it works and what the current distribution is. Looking at these figures, we can glean all kinds of ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities ...

The FDA has said it needs more information before it can approve Regenxbio's gene therapy for Hunter syndrome, driving the company's share price down 15% after-hours. In a complete response letter ...

Are you facing the FPS drops issue while playing on Valorant? Does Valorant FPS drop to 0 or 1 or a low figure? Here is a full guide to fix the issue of low FPS or FPS drops in Valorant on your ...

What are the allegations? Robbins LLP is Investigating Allegations that REGENXBIO, Inc. (RGNX) Misled Investors Regarding the Viability of its Drug Candidate RGX-111 According to the complaint, ...